Lineage Cell Therapeutics, Inc. (TLV:LCTX)
404.90
-25.80 (-5.99%)
Aug 28, 2025, 5:24 PM IDT
Lineage Cell Therapeutics Employees
As of December 31, 2024, Lineage Cell Therapeutics had 77 total employees, including 70 full-time and 7 part-time employees. The number of employees increased by 2 or 2.67% compared to the previous year.
Employees
77
Change (1Y)
2
Growth (1Y)
2.67%
Revenue / Employee
496.93K ILS
Profits / Employee
-1.86M ILS
Market Cap
928.22M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 77 | 2 | 2.67% |
Dec 31, 2023 | 75 | -3 | -3.85% |
Dec 31, 2022 | 78 | 17 | 27.87% |
Dec 31, 2021 | 61 | 6 | 10.91% |
Dec 31, 2020 | 55 | 0 | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Teva Pharmaceutical Industries | 35,686 |
Danel (Adir Yeoshua) | 4,290 |
Kamada | 420 |
Bait Bakfar | 227 |
BrainsWay | 120 |
SofWave Medical | 126 |
Novolog (Pharm-Up 1966) | 936 |
Ilex Medical | 178 |